Antimalarial drug mefloquine inhibits nuclear factor kappa B signaling and induces apoptosis in colorectal cancer cells

por Xu, Xin, Wang, Jun, Han, Kunkun, Li, Shaoyan, Xu, Feng, Yang, Yili
Publicado 2018

Ring finger protein 6 promotes breast cancer cell proliferation by stabilizing estrogen receptor alpha

por Zeng, Yuanying, Xu, Xin, Wang, Siyu, Zhang, Zubin, Liu, Yan, Han, Kunkun, Cao, Biyin, Mao, Xinliang
Publicado 2017

Ubiquitin specific peptidase 5 regulates colorectal cancer cell growth by stabilizing Tu translation elongation factor

por Xu, Xin, Huang, Aiwen, Cui, Ximao, Han, Kunkun, Hou, Xiaodan, Wang, Qun, Cui, Long, Yang, Yili
Publicado 2019

Clioquinol induces pro-death autophagy in leukemia and myeloma cells by disrupting the mTOR signaling pathway

por Cao, Biyin, Li, Jie, Zhou, Xiumin, Juan, Jiaxiang, Han, Kunkun, Zhang, Zubin, Kong, Yan, Wang, Jianrong, Mao, Xinliang
Publicado 2014

An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathway

por Xu, Xin, Han, Kunkun, Zhu, Jingyu, Mao, Hongwu, Lin, Xu, Zhang, Zubin, Cao, Biyin, Zeng, Yuanying, Mao, Xinliang
Publicado 2016

Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization

por Han, Kunkun, Xu, Xin, Chen, Guodong, Zeng, Yuanying, Zhu, Jingyu, Du, Xiaolin, Zhang, Zubin, Cao, Biyin, Liu, Zhaopeng, Mao, Xinliang
Publicado 2014

SC06, a novel small molecule compound, displays preclinical activity against multiple myeloma by disrupting the mTOR signaling pathway

por Han, Kunkun, Xu, Xin, Xu, Zhuan, Chen, Guodong, Zeng, Yuanying, Zhang, Zubin, Cao, Biyin, Kong, Yan, Tang, Xiaowen, Mao, Xinliang
Publicado 2015

Inhibition of Ubiquitin Specific Protease 1 Sensitizes Colorectal Cancer Cells to DNA-Damaging Chemotherapeutics

por Xu, Xin, Li, Shaoyan, Cui, Ximao, Han, Kunkun, Wang, Jun, Hou, Xiaodan, Cui, Long, He, Songbing, Xiao, Jiecheng, Yang, Yili
Publicado 2019

A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma

por Zhu, Jingyu, Wang, Man, Yu, Yang, Qi, Huixin, Han, Kunkun, Tang, Juan, Zhang, Zubin, Zeng, Yuanying, Cao, Biyin, Qiao, Chunhua, Zhang, Hongjian, Hou, Tingjun, Mao, Xinliang
Publicado 2014

Correction: A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma

por Zhu, Jingyu, Wang, Man, Yu, Yang, Qi, Huixin, Han, Kunkun, Tang, Juan, Zhang, Zubin, Zeng, Yuanying, Cao, Biyin, Qiao, Chunhua, Zhang, Hongjian, Hou, Tingjun, Mao, Xinliang
Publicado 2019

A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway

por Zhang, Zubin, Mao, Hongwu, Du, Xiaolin, Zhu, Jingyu, Xu, Yujia, Wang, Siyu, Xu, Xin, Ji, Peng, Yu, Yang, Cao, Biyin, Han, Kunkun, Hou, Tingjun, Xu, Zhuan, Kong, Yan, Jiang, Gaofeng, Tang, Xiaowen, Qiao, Chunhua, Mao, Xinliang
Publicado 2016

Correction: A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway

por Zhang, Zubin, Mao, Hongwu, Du, Xiaolin, Zhu, Jingyu, Xu, Yujia, Wang, Siyu, Xu, Xin, Ji, Peng, Yu, Yang, Cao, Biyin, Han, Kunkun, Hou, Tingjun, Xu, Zhuan, Kong, Yan, Jiang, Gaofeng, Tang, Xiaowen, Qiao, Chunhua, Mao, Xinliang
Publicado 2016